2Chen YJ,Wu CY,Shen JL. Predicting fators of malignancy in dermatomyositis and polymyositis : a case-control study. Br J Dermatol, 2001,144:825-831.
3Mebazaa A, Boussen H, Nouiva R,et al. Dermatomysitis and malignancy Tunisia:a multicenter national restrospective study of 20 cases. J Am Acad Dermatol ,2003,48:530-534.
4Vardy J, Wong E, Izard M, et al. Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis : a case report with literature review. Anticaner drugs ,2002,13:327-330.
5Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and ploymyositis:a population -based study.Lancet .2001.357:96-100.
6Sparsa A, Liozon E, Herrmann F, et al. Routine VS extensive malignancy search for adult dermatomyositis and ploymyositis: a study of 40 patients. Arch Dermatol,2002,138 : 885-890.
7Ang P, Sugeng MW, Chua SH. Classical and amyopothic dermatomyositis seen at the national skin center of singapore:3-years restropective review of their clinical characteristics and association with malignancy.Ann Acad Med, singapore ,2000,29:219-223.
8Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow -up implications: a Scottish population-based cohort study. Br J cancer,2001,85:41-45.
9Wakata N, Kufihara T, Saito E, et al. Polymyositis and dermatomyositis associated with malignancy: a 30-years restrospective study. Int j Dermatol.2002.41:729-734.
10Yeh CN ,Chen SC, Hwang TL, et al. Breast carcinoma in patients with dermatomyositis:a retrospective analysis of eight eases. Gung Med J,2002.25:374-380.
